NO20022592L - Forbindelser og fremgangsmåter for behandling og diagnose av Chlamydia-infeksjoner - Google Patents

Forbindelser og fremgangsmåter for behandling og diagnose av Chlamydia-infeksjoner

Info

Publication number
NO20022592L
NO20022592L NO20022592A NO20022592A NO20022592L NO 20022592 L NO20022592 L NO 20022592L NO 20022592 A NO20022592 A NO 20022592A NO 20022592 A NO20022592 A NO 20022592A NO 20022592 L NO20022592 L NO 20022592L
Authority
NO
Norway
Prior art keywords
diagnosis
compounds
treatment
methods
chlamydia infections
Prior art date
Application number
NO20022592A
Other languages
English (en)
Other versions
NO20022592D0 (no
Inventor
Peter Probst
Ajay Bhatia
Yasir A W Skeiky
Steven P Fling
John Scholler
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/556,877 external-priority patent/US6432916B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of NO20022592D0 publication Critical patent/NO20022592D0/no
Publication of NO20022592L publication Critical patent/NO20022592L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20022592A 1999-12-03 2002-05-31 Forbindelser og fremgangsmåter for behandling og diagnose av Chlamydia-infeksjoner NO20022592L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US45468499A 1999-12-03 1999-12-03
US09/556,877 US6432916B1 (en) 1998-12-08 2000-04-19 Compounds and methods for treatment and diagnosis of chlamydial infection
US09/598,419 US6565856B1 (en) 1998-12-08 2000-06-20 Compounds and methods for treatment and diagnosis of chlamydial infection
PCT/US2000/032919 WO2001040474A2 (en) 1999-12-03 2000-12-04 Compounds and methods for treatment and diagnosis of chlamydial infection

Publications (2)

Publication Number Publication Date
NO20022592D0 NO20022592D0 (no) 2002-05-31
NO20022592L true NO20022592L (no) 2002-07-19

Family

ID=27412613

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022592A NO20022592L (no) 1999-12-03 2002-05-31 Forbindelser og fremgangsmåter for behandling og diagnose av Chlamydia-infeksjoner

Country Status (16)

Country Link
US (1) US6565856B1 (no)
EP (1) EP1238084A2 (no)
JP (1) JP2003515343A (no)
KR (1) KR20020073136A (no)
CN (1) CN1437652A (no)
AU (1) AU1815901A (no)
BR (1) BR0016066A (no)
CA (1) CA2390088A1 (no)
CZ (1) CZ20021897A3 (no)
HU (1) HUP0203705A2 (no)
IL (1) IL149754A0 (no)
MX (1) MXPA02005504A (no)
NO (1) NO20022592L (no)
NZ (1) NZ518917A (no)
PL (1) PL355977A1 (no)
WO (1) WO2001040474A2 (no)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030219453A1 (en) * 1998-03-19 2003-11-27 Smithkline Beecham Biologicals, Sa Vaccines
US7459524B1 (en) * 1997-10-02 2008-12-02 Emergent Product Development Gaithersburg Inc. Chlamydia protein, sequence and uses thereof
EP1105489A1 (en) 1998-08-20 2001-06-13 Aventis Pasteur Limited Nucleic acid molecules encoding pomp91a protein of chlamydia
US6686339B1 (en) 1998-08-20 2004-02-03 Aventis Pasteur Limited Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
AU5366099A (en) 1998-08-20 2000-03-14 Connaught Laboratories Limited Nucleic acid molecules encoding inclusion membrane protein of (chlamydia)
US6649370B1 (en) 1998-10-28 2003-11-18 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
US6607730B1 (en) 1998-11-02 2003-08-19 Aventis Pasteur Limited/Aventis Pasteur Limitee Chlamydia antigens and corresponding DNA fragments and uses thereof
AU3790900A (en) 1998-12-01 2000-06-19 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
US20080213264A1 (en) * 1998-12-08 2008-09-04 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6565856B1 (en) 1998-12-08 2003-05-20 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20020061848A1 (en) * 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US6555115B1 (en) 1998-12-08 2003-04-29 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
CN100365120C (zh) 1998-12-08 2008-01-30 科里克萨有限公司 用于治疗及诊断衣原体感染的化合物和方法
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
US7297341B1 (en) 1998-12-23 2007-11-20 Sanofi Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
US6808713B1 (en) 1998-12-28 2004-10-26 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
JP2002541766A (ja) 1998-12-28 2002-12-10 アベンティス、パストゥール、リミテッド クラミジア抗原および対応するｄｎａ断片ならびにその使用
GB9902555D0 (en) 1999-02-05 1999-03-24 Neutec Pharma Plc Medicament
EP2172214A3 (en) 1999-03-12 2011-03-16 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
WO2000066739A2 (en) 1999-05-03 2000-11-09 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
CA2385325C (en) 1999-09-20 2012-04-10 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
US6632663B1 (en) 1999-09-22 2003-10-14 Aventis Pasteur Limited DNA immunization against chlamydia infection
EP1240331B1 (en) 1999-12-22 2010-04-07 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
AU2001255596A1 (en) * 2000-04-21 2001-11-07 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6919187B2 (en) * 2000-04-21 2005-07-19 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
EP1282718B1 (en) 2000-05-08 2006-12-20 Sanofi Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
ATE440861T1 (de) 2000-07-03 2009-09-15 Novartis Vaccines & Diagnostic Immunisierung gegen chlamydia pneumoniae
US7731980B2 (en) * 2000-10-02 2010-06-08 Emergent Product Development Gaithersburg Inc. Chlamydia PMP proteins, gene sequences and uses thereof
US7537772B1 (en) * 2000-10-02 2009-05-26 Emergent Product Development Gaithersburg Inc. Chlamydia protein, gene sequence and the uses thereof
GB0103169D0 (en) * 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
US6925469B2 (en) * 2001-03-30 2005-08-02 Intertainer, Inc. Digital entertainment service platform
ES2386386T3 (es) 2001-12-12 2012-08-20 Novartis Vaccines And Diagnostics S.R.L. Inmunización contra Chlamydia trachomatis
GB0203403D0 (en) 2002-02-13 2002-04-03 Chiron Spa Chlamydia cytotoxic-T cell epitopes
AU2004289295B2 (en) * 2003-11-10 2010-08-12 The Uab Research Foundation Compositions for reducing bacterial carriage and CNS invasion and methods of using same
CN101184504A (zh) 2005-03-31 2008-05-21 葛兰素史密丝克莱恩生物有限公司 针对衣原体感染的疫苗
US8541007B2 (en) 2005-03-31 2013-09-24 Glaxosmithkline Biologicals S.A. Vaccines against chlamydial infection
US9259463B2 (en) * 2006-01-16 2016-02-16 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Chlamydia vaccine
US20110002962A1 (en) * 2006-08-17 2011-01-06 The Uab Research Foundation Immunogenic PcpA Polypeptides and Uses Thereof
NL1033345C1 (nl) * 2007-02-06 2008-08-07 Vereniging Voor Christelijk Ho Werkwijze voor het detecteren van Chlamydia trachomatis en een kit daarvoor.
JP2010526070A (ja) * 2007-05-01 2010-07-29 ザ ボード オブ リージェンツ オブ ザ ユニバーシティ オブ テキサス システム Ｃｈｌａｍｙｄｉａ感染及び疾患の診断ならびに治療のための薬剤としてのＣｈｌａｍｙｄｉａ抗原
AU2008284352A1 (en) * 2007-08-03 2009-02-12 President And Fellows Of Harvard College Chlamydia antigens
US7892567B2 (en) * 2007-10-01 2011-02-22 Board Of Regents, The University Of Texas System Methods and compositions for immunization against chlamydial infection and disease
AU2008331800A1 (en) * 2007-12-03 2009-06-11 President And Fellows Of Harvard College Chlamydia antigens
JP4798125B2 (ja) * 2007-12-13 2011-10-19 株式会社デンソー 照度センサ
US9068007B2 (en) 2008-10-09 2015-06-30 Board Of Regents, The University Of Texas System Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease
US8204859B2 (en) * 2008-12-10 2012-06-19 Commvault Systems, Inc. Systems and methods for managing replicated database data
WO2010100632A2 (en) 2009-03-06 2010-09-10 Novartis Ag Chlamydia antigens
WO2011118496A1 (ja) 2010-03-23 2011-09-29 和光純薬工業株式会社 クラミジア・トラコマティス検出用プライマー及びプローブ、並びにこれを用いたクラミジア・トラコマティスの検出方法
PL3762009T3 (pl) 2018-03-08 2022-09-12 Applied Molecular Transport Inc. Pochodzące z toksyny konstrukty dostarczające do dostarczania doustnego
SG11202104734YA (en) * 2018-11-07 2021-06-29 Applied Molecular Transport Inc Cholix-derived carriers for oral delivery of heterologous payload
MX2022001975A (es) 2019-08-16 2022-03-11 Applied Molecular Transport Inc Composiciones, formulaciones y produccion y purificacion de interleucinas.
CN112779248B (zh) * 2021-02-04 2022-12-02 杭州遂曾生物技术有限公司 一种沙眼衣原体一体化核酸检测卡盒

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4118469A (en) 1976-04-27 1978-10-03 Research Corporation Antigen for trachoma lymphogranuloma venereum (LGV) and non-gonococcal urethritis (NGU)
US4497863A (en) 1984-03-07 1985-02-05 Milliken Research Corporation Laminated weft insertion fabric
US5166053A (en) 1990-02-23 1992-11-24 Miles Inc. Specimen adequacy control for chlamydia assays
JP3018553B2 (ja) 1990-05-08 2000-03-13 日立化成工業株式会社 クラミジア・トラコマティス抗体測定方法及びクラミジア・トラコマティス感染症診断用製剤
US5549978A (en) 1992-10-30 1996-08-27 Kabushiki Kaisha Toshiba Magnetoresistance effect element
CN100365017C (zh) 1994-09-20 2008-01-30 日立化成工业株式会社 肺炎衣原体抗原多肽
GB9516293D0 (en) 1995-08-09 1995-10-11 Immunova Ltee Novel peptides and their use as vaccines
WO1998002546A2 (en) 1996-07-12 1998-01-22 University Of Manitoba Dna immunization against chlamydia infection
US6464979B1 (en) 1996-09-12 2002-10-15 Aventis Pasteur Limited Chlamydial vaccines and methods of preparation thereof
KR20010032336A (ko) 1997-11-21 2001-04-16 브랑디 빠스깔 클라미디아 뉴모니아 게놈 서열과 폴리펩티드, 이의 단편및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도
KR100760221B1 (ko) 1997-11-28 2007-10-30 세로노 제네틱스 인스티튜트 에스.에이. 클라미디아 트라코마티스 게놈 서열과 폴리펩티드, 이의단편 및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도
BR9909472A (pt) 1998-04-07 2001-09-11 Corixa Corp Polipeptìdeo purificado, processo para prevenir tuberculose, e, composição farmacêutica
CN100365120C (zh) 1998-12-08 2008-01-30 科里克萨有限公司 用于治疗及诊断衣原体感染的化合物和方法
US6565856B1 (en) 1998-12-08 2003-05-20 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection

Also Published As

Publication number Publication date
HUP0203705A2 (hu) 2003-03-28
EP1238084A2 (en) 2002-09-11
CN1437652A (zh) 2003-08-20
NZ518917A (en) 2004-06-25
BR0016066A (pt) 2003-06-10
KR20020073136A (ko) 2002-09-19
NO20022592D0 (no) 2002-05-31
AU1815901A (en) 2001-06-12
PL355977A1 (en) 2004-05-31
IL149754A0 (en) 2002-11-10
WO2001040474A2 (en) 2001-06-07
US6565856B1 (en) 2003-05-20
CZ20021897A3 (cs) 2003-02-12
WO2001040474A3 (en) 2002-03-07
JP2003515343A (ja) 2003-05-07
CA2390088A1 (en) 2001-06-07
MXPA02005504A (es) 2002-10-31

Similar Documents

Publication Publication Date Title
NO20022592D0 (no) Forbindelser og fremgangsmåter for behandling og diagnose av Chlamydia-infeksjoner
NO20016427D0 (no) Blandinger og fremgangsmåter for behandling av diagnose av lungekreft
NO20013002D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av ovariekreft
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
NO20030714L (no) Blandinger og fremgangsmåter for behandling og diagnose av HER-2/NEU-assosierte maligniteter
NO20023402D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av prostatakreft
NO995690D0 (no) Forbindelser for diagnose av tuberkulose og metoder for deres anvendelse
DE60022754D1 (de) Diagnose und behandlung von arrhythmien
DK200001852A (da) Manipuleringssektion til et endoskopisk behandlingsinstrument
DK1239872T3 (da) Enzymbehandling til fordøjelseskanal-infektioner
NO20022087L (no) Fremgangsmåte for behandling av diabetes
NO20015288D0 (no) Anvendelse av makrolide forbindelser for behandling av tört öye
NO991693D0 (no) Forbindelser og metoder for diagnose av tuberkulose
NO20014314D0 (no) Blandinger og metoder for behandling av stafylokokkisk infeksjon
NO20015542D0 (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
NO20013507L (no) Blandinger for behandling av inflammatoriske reaksjoner
NO20010953D0 (no) En fremgangsmÕte for behandling av stafylokokkal sykdom
NO991459D0 (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
EP1351699A4 (en) METHOD FOR IMPROVED DIAGNOSIS AND TREATMENT OF MYCOBACTERIAL INFECTIONS
ID26097A (id) Proses pembuatan pakaian luar sekali pakai
NO20026219L (no) Forbindelser for behandling av svekket fundisk relaksasjon
NO20012541D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
NO20013651D0 (no) Anvendelse av fosfororganiske forbindelser for profylaktisk og terapeutisk behandling av infeksjoner
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
PT1200447E (pt) Oxazinocarbazoles para o tratamento de doencas do snc

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application